Fuzheng Kang’ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial

Controlled Trial ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Randomized Controlled ◽

Gefitinib plus Fuzheng Kang’ai Formula (扶正抗癌方) in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial

Chinese Journal of Integrative Medicine ◽

10.1007/s11655-017-2819-8 ◽

2017 ◽

Vol 24 (10) ◽

pp. 734-740 ◽

Cited By ~ 6

Author(s):

Xiao-bing Yang ◽

Xiao-shu Chai ◽

Wan-yin Wu ◽

Shun-qin Long ◽

Hong Deng ◽

...

Keyword(s):

Lung Cancer ◽

Randomized Controlled Trial ◽

Growth Factor ◽

Controlled Trial ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Randomized Controlled ◽

Real-World Treatment Patterns, Epidermal Growth Factor Receptor (EGFR) Testing and Outcomes in EGFR-Mutated Advanced Non-small Cell Lung Cancer Patients in Belgium: Results from the REVEAL Study

Drugs - Real World Outcomes ◽

10.1007/s40801-021-00243-w ◽

2021 ◽

Author(s):

Kristof Cuppens ◽

◽

Liesbet Lodewyckx ◽

Ingel Demedts ◽

Lore Decoster ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor Receptor ◽

Treatment Patterns ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Reveal Study ◽

Epidermal Growth ◽

Egfr Mutated

Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.

Oncology Reports ◽

10.3892/or.7.3.603 ◽

2000 ◽

Cited By ~ 13

Author(s):

Y Ohsaki ◽

S Tanno ◽

Y Fujita ◽

E Toyoshima ◽

S Fujiuchi ◽

...

Keyword(s):

Lung Cancer ◽

Poor Prognosis ◽

Growth Factor Receptor ◽

Small Cell ◽

Receptor Expression ◽

Small Cell Lung ◽

P53 Overexpression ◽

Lung Cancer Patients ◽

Objective regressions in non-small cell lung cancer patients treated in Phase I trials of oral ZD1839 (IressaTM), a selective tyrosine kinase inhibitor that blocks the epidermal growth factor receptor (EGFR)

Lung Cancer ◽

10.1016/s0169-5002(00)80233-0 ◽

2000 ◽

Vol 29 (1) ◽

pp. 72 ◽

Cited By ~ 34

Author(s):

M.G Kris ◽

R Herbst ◽

D Rischin ◽

P LoRusso ◽

J Baselga ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Phase I Trials ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Phosphorylation, But Not Overexpression, of Epidermal Growth Factor Receptor Is Associated With Poor Prognosis of Non-Small Cell Lung Cancer Patients

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics ◽

10.3727/096504003108748348 ◽

2003 ◽

Vol 13 (5) ◽

pp. 289-298 ◽

Cited By ~ 52

Author(s):

Takanori Kanematsu ◽

Seiji Yano ◽

Hisanori Uehara ◽

Yoshimi Bando ◽

Saburo Sone

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Poor Prognosis ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth Factor Receptor exon 20 insertion variants in Non-Small Cell Lung Cancer patients

Critical Reviews in Oncology/Hematology ◽

10.1016/j.critrevonc.2021.103536 ◽

2021 ◽

pp. 103536

Author(s):

Umberto Malapelle ◽

Sara Pilotto ◽

Maria Lucia Reale ◽

Francesco Passiglia ◽

Pasquale Pisapia ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Exon 20

Afatinib treatment in a large real‐world cohort of non‐small cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation

International Journal of Cancer ◽

10.1002/ijc.33821 ◽

2021 ◽

Author(s):

Chi‐Hsien Huang ◽

Jia‐Shiuan Ju ◽

Tzu‐Hsuan Chiu ◽

Allen Chung‐Cheng Huang ◽

Pi‐Hung Tung ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Icotinib improves progression free survival in epidermal growth factor receptor positive non-small cell lung cancer patients

Translational Cancer Research ◽

10.21037/tcr.2018.01.15 ◽

2018 ◽

Vol 7 (S1) ◽

pp. S26-S30

Author(s):

Pranav Gupta ◽

Anna Maria Barbuti ◽

De-Shen Wang ◽

Qingbin Cui ◽

Zhe-Sheng Chen

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Growth Factor Receptor ◽

Progression Free Survival ◽

Small Cell ◽

Small Cell Lung ◽

Free Survival ◽

Lung Cancer Patients ◽

Epidermal Growth Factor Receptor Mutations in Resectable Non-Small Cell Lung Cancer Patients and their Potential Role in the Immune Landscape

Medical Science Monitor ◽

10.12659/msm.920042 ◽

2019 ◽

Vol 25 ◽

pp. 8764-8776

Author(s):

Wei Xia ◽

Wenjun Mao ◽

Ruo Chen ◽

Rongguo Lu ◽

Feng Liu ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Potential Role ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2019.05.032 ◽

2019 ◽

Vol 117 ◽

pp. 107-115 ◽

Cited By ~ 7

Author(s):

Zong-Han Yao ◽

Wei-Yu Liao ◽

Chao-Chi Ho ◽

Kuan-Yu Chen ◽

Jin-Yuan Shih ◽

...

Keyword(s):

Lung Cancer ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Epidermal Growth ◽

Inhibitor Treatment